Blood Tumor Mutational Burden As a Predictive Biomarker in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC). Pjmcr 2026, 5 (2), 2361-2369. https://doi.org/10.66021/pakmcr1041.